ARG CEO Paul Bishop just received the following feedback from a Global Pharmaceutical Sponsor: ARG is a rare disease-focused contract […]
July 17, 2018Three New Kanbans As part of the 2018 corporate initiatives, an electronic version of Kanban is rolling out on a […]
July 17, 2018Why did you choose to pursue this MS? Shay: “My goal was to verify my industry knowledge through formal studies. […]
June 6, 2018The ARG SAB (Strategic Advisory Board) regularly convenes to discuss emerging trends and issues in rare diseases, adding to the […]
May 24, 2018Each quarter, ARG CEO Paul Bishop and President Lyle Camblos will share their thoughts and responses concerning relevant company and […]
May 22, 2018Jeff Cazeault, Head of Business Development at ARG, is in Washington, DC to attend the Alliance for Regenerative Medicine Annual […]
May 22, 2018